A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer

Sharad A. Ghamande, Michael H. Silverman, Warner Huh, Kian Behbakht, Greg Ball, Luceli Cuasay, Sidse O. Würtz, Nils Brunner, Michael A. Gold

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint Dive into the research topics of 'A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous Å6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences